Table 2 Characteristics of survivors of working age and independent variables of employment by the results of multiple logistic regression analysis
All patients (n = 140) | Inactive employment status (n = 47) | Active employment status (n = 93) | Univariate analysis | Multiple analysis | |||||
|---|---|---|---|---|---|---|---|---|---|
p | ODDS | 95% CI | p | ODDS | 95% CI | ||||
Age at survey > = 40 yr. | 76 (54%) | 15 (32%) | 61 (66%) | <0.001 | 4.357 | 2.038–9.316 | |||
vs. <40 yr. | 64 (46%) | 32 (68%) | 32 (34%) | ||||||
Age at dg. > = 30 yr. | 80 (57%) | 16 (34%) | 64 (69%) | <0.001 | 4.276 | 2.028–9.016 | 0.001 | 3.556 | 1.548–8.168 |
vs. <30 yr. | 60 (43%) | 31 (66%) | 29 (31%) | ||||||
Elapsed time > =10 yr. | 66 (47%) | 24 (51%) | 42 (45%) | 0.436 | 1.325 | 0.652–2.689 | |||
vs. <10 yr. | 74 (53%) | 23 (49%) | 51 (55%) | ||||||
Male | 69 (49%) | 23 (49%) | 46 (49%) | 0.953 | 0.979 | 0.485–1.975 | |||
vs. female | 71 (51%) | 24 (51%) | 47 (51%) | ||||||
Residence: village | 32 (23%) | 12 (26%) | 20 (22%) | 0.592 | 1.252 | 0.507–2.062 | |||
vs. city | 108 (77%) | 35 (74%) | 73 (78%) | ||||||
Education level: | |||||||||
elementary | 50 (36%) | 24 (53%) | 26 (28%) | 0.014 | 3.346 | 1.282–8.734 | 0.032 | 3.320 | 1.112–9.914 |
vs. college | 37 (27%) | 14 (30%) | 38 (41%) | ||||||
elementary | 0.568 | 1.336 | 0.494–3.609 | 0.235 | 1.967 | 0.644–6.007 | |||
vs. high school | 52 (37%) | 8 (17%) | 29 (31%) | ||||||
Single | 68 (50%) | 23 (52%) | 45 (49%) | 0.714 | 1.144 | 0.557–2.347 | |||
vs. live together | 68 (50%) | 21 (48%) | 47 (51%) | ||||||
Stage 3–4 | 73 (53%) | 24 (52%) | 41 (45%) | 0.399 | 1.357 | 0.668–2762 | |||
vs. 1–2 | 65 (47%) | 22 (48%) | 51 (55%) | ||||||
Bulk | 42 (32%) | 11 (27%) | 31 (34%) | 0.409 | 0.710 | 0.314–1.605 | |||
vs. without bulk | 90 (68%) | 30 (73%) | 60 (66%) | ||||||
B symptom | 61 (46%) | 20 (49%) | 41 (44%) | 0.691 | 1.161 | 0.555–2.433 | |||
vs. no B symptom | 71 (54%) | 21 (51%) | 50 (56%) | ||||||
ECOG 1–2 | 22 (17%) | 8 (20%) | 14 (16%) | 0.593 | 1.299 | 0.497–3.390 | |||
vs. ECOG 0 | 108 (83%) | 33 (80%) | 75 (84%) | ||||||
Comorbidity | 68 (49%) | 25 (53%) | 43 (44%) | 0.437 | 1.321 | 0.654–2.667 | |||
vs. no comorbidity | 72 (51%) | 22 (47%) | 50 (56%) | ||||||
Treatment: ABVD | 43 (31%) | 16 (34%) | 27 (30%) | 0.599 | 1.224 | 0.576–2.597 | |||
vs. other | 95 (69%) | 31 (66%) | 64 (70%) | ||||||
Irradiation | 103 (74%) | 35 (74%) | 68 (73%) | 0.864 | 1.072 | 0.482–2.387 | |||
vs. no irradiation | 37 (26%) | 12 (26%) | 25 (27%) | ||||||
Treatment response: PR | 72 (51%) | 4 (9%) | 5 (5%) | 0.484 | 1.637 | 0.418–6.409 | |||
vs. SD | 68 (49%) | 43 (81%) | 88 (95%) | ||||||
Treatment related side effect: yes | 72 (51%) | 36 (77%) | 36 (39%) | <0.001 | 5.182 | 2.343–11.460 | <0.001 | 5.254 | 2.196–12.524 |
vs. no | 68 (49%) | 11 (23%) | 57 (61%) | ||||||
Relapse | 21 (15%) | 7 (15%) | 14 (15%) | 0.980 | 0.983 | 0.369–2.641 | |||
vs. no relapse | 119 (85%) | 40 (85%) | 79 (85%) | ||||||